A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
- Status
- TERMINATED
- Phase
- PHASE1
A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of ORIC-101 in Combination With Anticancer Therapy
- Status
- TERMINATED
- Phase
- PHASE1